Cargando…
Culture and Process Change as a Priority for Patient Engagement in Medicines Development
Patient Focused Medicines Development (PFMD) is a not-for-profit independent multinational coalition of patients, patient stakeholders, and the pharmaceutical industry with interests across diverse disease areas and conditions. PFMD aims to facilitate an integrated approach to medicines development...
Autores principales: | Boutin, Marc, Dewulf, Lode, Hoos, Anton, Geissler, Jan, Todaro, Veronica, Schneider, Roslyn F., Garzya, Vincenzo, Garvey, Andrew, Robinson, Paul, Saffer, Tonya, Krug, Sarah, Sargeant, Ify |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302122/ https://www.ncbi.nlm.nih.gov/pubmed/28232876 http://dx.doi.org/10.1177/2168479016659104 |
Ejemplares similares
-
Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action
por: Hoos, Anton, et al.
Publicado: (2015) -
What do stakeholders expect from patient engagement: Are these expectations being met?
por: Boudes, Mathieu, et al.
Publicado: (2018) -
Public Engagement in Health Priority Setting in Low- and Middle-Income Countries: Current Trends and Considerations for Policy
por: Bolsewicz Alderman, Katarzyna, et al.
Publicado: (2013) -
Telerehabilitation Policy Report: Interprofessional Policy Principles and Priorities
por: Terrell, Evelyn Abrahante, et al.
Publicado: (2021) -
Co-creation of patient engagement quality guidance for medicines development: an international multistakeholder initiative
por: Deane, Katherine, et al.
Publicado: (2019)